Tara Donnelly is the interim Chief Digital Officer at NHS England.

She oversees a portfolio of citizen facing digital services, including the NHS website, NHS App and the development of digital services which meet people’s needs, target prevention and offer a personalised experience.

Tara is on secondment from her role as Chief Executive of the Health Innovation Network. She has led the Health Innovation Network for over three years and is also a non-executive director at the Nuffield Trust.

She has an extensive background in leadership roles within the NHS and the voluntary and community sector and has spent the past 18 years at board level. She has worked in the NHS for 30 years, with her first role being as a Ward Housekeeper when she was 18.

Alan is a senior staff clinical research scientist in Google Health who leads the clinical team’s translational research efforts, with a particular focus on bridging new ML developments and health-oriented research. He focuses on machine learning for medical imaging across multiple fields: radiology, ophthalmology and dermatology, with interests in AI safety, robustness and data-efficiency for realising real-world clinical impact. Alan is an honorary Lecturer in Vascular Surgery at Imperial College in London where he continues to see patients and supervise PhD students. He did his MA in Neuroscience and Medical Degree (MBBChir) at the University of Cambridge, followed by specialist training in surgery in the London Deanery, where he completed his Membership of the Royal College of Surgeons (MRCS), PhD in Vascular Surgery and was appointed as a NIHR Clinical Lecturer. In 2017 he joined DeepMind’s health research team and in 2019 joined Google Health. He has published over 150 peer-reviewed articles, including first-author studies in the New England Journal of Medicine and The Lancet prior to DeepMind/Google, where he subsequently co-authored landmark papers in Nature and Nature Medicine on deep learning systems for mammography, ophthalmology and electronic health records.

Dr. Wei Fan is the executive director of Tencent Hippocrates Labs. His main interests are in using various artificial intelligence techniques-based digital therapeutics & digital biomarker for clinical problems, such as motion disorder syndrome (e.g., Parkinson’s disease), cancer radiotherapy planning, heart failure early detection, etc. Dr. Fan received Ph. D. in Computer Science from Columbia University. He has been working in AI since 1995. He has over 150 top journals and conference papers with h-index of 58. He has received multiple best paper awards in top AI conferences and competitions. He served as the associate editor of ACM Transaction on Knowledge Discovery and Data Mining.

Prof. Dr. med. Mathias Goyen is currently the Chief Medical Officer EMEA for GE Healthcare, a $17 billion division of General Electric. Mathias is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe, the Middle East & Africa. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products

Mathias began his career as a diagnostic Radiologist working at Essen and Hamburg/Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg/Germany in 2010. Mathias’ previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Mathias established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies.

Mathias holds a medical degree (MD) from the University of Bochum, Germany. He has been secretary general of the German Chinese Society of Medicine, Berlin, from 2005 – 2019.

Dr Indra Joshi is the Director of AI at NHSX and runs the NHS AI Lab – a £250m programme to accelerate the safe adoption of ethical and effective AI-driven technologies to the front line of health and care. 

Indra has a unique portfolio with experience stretching across digital health, data and AI strategy and delivery; whilst remaining true to her professional training as an emergency medic.   

She is a Founding Member of One HealthTech – a network which campaigns for the need and importance of better inclusion of all backgrounds, skillsets and disciplines in health technology. Alongside she is an associate editor for BMJ Leader, a member of the WHO digital health expert group, a consultant on digital health, and most importantly a mum to two wonderful little munchkins.

Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry.  Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain.

Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare.

Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.

Samantha Roberts has recently been appointed as Chief Executive of the Accelerated Access Collaborative, the national umbrella organisation for health innovation, hosted in NHS England and NHS Improvement.

She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before undertaking an MBA and joining McKinsey and Company, where she worked in a wide range of industries before specialising in healthcare.

After McKinsey she moved into the NHS as a senior manager at a large teaching hospital in London (UCLH) and a director in an Academic Health Sciences Centre and Network (UCLPartners). Before taking on the role of Director of Innovation, Research and Life Sciences at NHS England and NHS Improvement last year.

Over the last five years she has become involved in research, working with health economic models to inform evidence-based policy, initially at the London School of Economics before moving to the University of Oxford to undertake a DPhil (PhD).

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

Christina is an innovation senior manager at NHS England and NHS Improvement. After working for many years as an adult nurse specialising in critical care, Christina moved to a quality improvement and patient safety role in an acute Trust, particularly developing the Women and Children’s service. In 2018 Christina joined the Innovation, Research and Life sciences team supporting innovation programmes which challenge traditional ways of working to improve patient care. Christina’s MSc in Implementation and Improvement Science and recent work have led her to focus on the factors which affect successful adoption and spread of innovation into healthcare, covering a wide
range of innovations including MedTech, diagnostic, digital and AI solutions. Christina leads the AI Award delivery team: the team supports the AAC ambition to improve the pipeline for innovations which meet the needs of patients and the National Health Service.

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data. This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

Danny is the AI Clinical Lead at the Guy’s Cancer Centre, which is partnering with the newly established AI Evaluation Unit at the King’s Technology Evaluation Centre (KiTEC), King’s College London, on the clinical evaluation of AI technology in cancer care.

Danny has formerly held posts as Director of Public health for the London Borough of Lewisham and the City of Newcastle, and as Senior Lecturer in Epidemiology and Health Services Research at Newcastle University and Dundee University. Danny has developed national clinical guidelines for the NHS in Scotland, conducted large randomised trials, and developed Patient Reported Outcome measures recommended by the US FDA, used with patients across the NHS in England and throughout the world. 

An innovative operational strategy expert with extensive and wide-ranging experience relating to strategic programme leadership, planning and management of clinical trials with responsibility for global clinical programmes (US, Europe and Japan). Peju started her career working in early drug discovery and exploratory phase focused on the transition of early stage assets to clinical development. Following this, she moved into programme management of late stage assets responsible for key clinical programmes within Eli Lilly, Sanofi Aventis, Pfizer and Takeda before joining BenevolentAI as Clinical Development Operations Leader.

Javier has devoted his career to the fields of Marketing and Business Development. During the early years of his working life, he developed his professional skills in the Marketing area of renowned companies of the Food & Beverage industry. Afterwards, he moved to Business Development, where he quickly jumped to the international scenario, managing corporate sales in different continents. By 2017, he was managing Sales Department at a multinational company for the whole African Continent.

In 2017, Javier founded IOMED together with two other business partners. At IOMED, Javier has been CEO, managing the company’s strategy, business development, public relations and investors’ relations.

A former Darzi Fellow, Fay joined the Health Innovation Network from the London Ambulance Service where she was employed as Paramedic team leader, before which she has worked as a physiotherapist and gained a MSc in Healthcare Leadership at King’s College London. Fay’s HIN portfolio is primarily concerned with the promotion of healthy living and the prevention of illness and disability affecting older people. She is leading on the NHSX Innovation Collaboration for London which sees the London STPs/ICSs supporting the implementation and evaluation of remote monitoring in care homes across the capital.

Professor Gilbert is Head of Department of Radiology at the University of Cambridge. Her clinical work and research is focused on imaging techniques relating to breast cancer and oncology.  She is interested in multimodal functional imaging with MRI and PET of the tumour environment using breast cancer as a model and correlating this with the tumour genetic profile.  She undertakes research in stratified breast screening using Abbreviated MRI, Tomosynthesis, Whole Breast Ultrasound and Contrast Enhanced Mammography. She maintains a strong interest in musculo-skeletal imaging.  She evaluates new imaging technology and is currently working on Artificial Intelligence in Imaging. 

Since 2012 Professor Gilbert has been awarded fifteen competitive grants worth over £20M. She was a member of the NIHR HTA Board and then the EME Board and is on a number of advisory panels.

Professor Gilbert has 236 peer reviewed publications, 5 book chapters and numerous conference abstracts.   She is a regular speaker at international Radiology conferences in Chicago and Vienna and is current President of the European Society of Breast Imaging and was awarded the Gold Medal from the European Society of Radiology in 2021.

Stephanie is an NHS Clinical Entrepreneur and Senior Research Fellow at UCL and UCLH where she was awarded a Doctorate in Clinical Research in Oncology. Research Interests include Integrated Data Models for Cancer Monitoring, Survivorship and Longevity. A Clinician-Scientist with over 10 years experience, Stephanie has served on council on a National Cancer Society (BGCS) and is the Healthcare Ambassador of the global organisation Women in AI (WAI). She is a Scientific Advisor to WILD.AI and the Havas Lynx Faculty and on the Advisory Committee of the Social Impact Community, the Conduit, London.

Dr Marc Farr started his career at Experian, where he was head of public sector consulting. He went on to become head of development at Dr Foster, and has been director of information at East Kent Hospitals University NHS Foundation Trust for seven years. He is also founder and chief executive of Beautiful Information.

Beautiful Information is a first of kind NHS / private partnership, that delivers real time information to NHS trusts to help them plan and resource clinical services. It’s vision is to connect patients, clinicians and managers through beautiful information, to make healthcare simple and transparent.

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

Erik de Heus has been at the helm of SkinVision as CEO since 2017. With over 20 years of global experience, Erik has both the breadth of experience and proven knowledge to drive the health tech company’s mission forward.

Throughout his previous work within Hewlett-Packard and Royal Philips Electronics, he has experience building new products and services with a global scope. For Hewlett-Packard, he worked and lived in Geneva and Mountain View. In various management positions, working across cultures with different corporate and entrepreneurial teams, he created and managed different solutions in the technology, finance, services, health, and wellbeing spaces.

In addition to this global experience, Erik was CEO of a Dutch renewable energy company Oxxio. Under his management, the company grew in the timeframe from inception to generate over € 500,000,000. In the buy and build strategy, Oxxio acquired and integrated four companies in two years. OXXIO was acquired in 2005 by Centrica Preventing an IPO planned for mid-2005. Erik holds a Master degree in Business Economics from the Free University of Amsterdam.

Kevin Goodwin is a 32 year veteran innovator from the global ultrasound business. In 1998 he founded Sonosite, the world’s first ultrasound company to miniaturize & simplify ultrasound technology. Today, Kevin is engaged in another first: applying artificial intelligence to recognize anatomy and quickly guide medical practitioners of all skill levels in easily looking into the body, and to make more accurate diagnostic assessments in just seconds. In 2015, Kevin co-founded EchoNous for the purpose of creating intelligent medical tools with extremely miniaturized, diagnostic grade technology.